European Journal of Haematology sep'18

Epstein‐Barr virus post‐transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation

European Journal of Haematology Fecha de publicación: 27 june 2018 DOI: https://doi.org/10.1111/ejh.13131 Autores: Yuhua Ru, Jia Chen, Depei Wu Background: Epstein‐Barr virus (EBV) viremia and post‐transplant lymphoproliferative disease (PTLD) are severe complications...
American Journal of Hematology sep'18

Long‐term survival and loss in expectancy of life in a population‐based cohort of 7114...

American Journal of Hematology Fecha de publicación: 17 may 2018 DOI: https://doi.org/10.1002/ajh.25147 Autores: Sara Ekberg, Mats Jerkeman, Per‐Ola Andersson, Gunilla Enblad, Björn E Wahlin, Sverker Hasselblom, Therese M. Andersson, Sandra...
European Journal of Hematology

Rapidly changing myeloma epidemiology in the general population: Increased incidence, older patients, and longer...

European Journal of Haematology Fecha de publicación: 20 April 2018 DOI: https://doi.org/10.1111/ejh.13083 Autores: Ingemar Turesson, Magnus Bjorkholm, Cecilie Hveding Blimark, Sigurdur Kristinsson, Ramon Velez, Ola Landgren. Background: The incidence of multiple...
American Journal of Hematology

Multiple myeloma: 2018 update on diagnosis, risk‐stratification, and management

American Journal of Hematology Fecha de publicación: 16 August 2018 8 DOI: https://doi.org/10.1002/ajh.25117 Autores: S. Vincent Rajkumar Background: Multiple myeloma accounts for approximately 10% of hematologic malignancies. The diagnosis requires...
European Journal of Hematology

Myc protein overexpression is a feature of progression and adverse prognosis in multiple myeloma

European Journal of Haematology Fecha de publicación: 12 July 2018 DOI: https://doi.org/10.1111/ejh.13141 Autores: Hanne E. H. Møller, Birgitte S. Preiss, Per Pedersen, Brian Østergaard, Mikael Frederiksen, Niels Abildgaard, Michael B. Møller. Background: Prognostic...
American Journal of Hematology

Description and prognostic significance of the kinetics of minimal residual disease status in adults...

American Journal of Hematology Fecha de publicación: 10 January 2018 DOI: https://doi.org/10.1002/ajh.25030 Autores: Philip A. Stevenson, Brent L. Wood, Pamela S. Becker, Paul C. Hendrie, Brenda M. Sandmaier, Jerald L....
The Lancet Haematology

Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

The Lancet Haematology Fecha de publicación: 12 June 2018 DOI: https://doi.org/10.1016/S2352-3026(18)30051-6 Autores: Gita Thanarajasingam, Lori M Minasian, Frederic Baron, Franco Cavalli, R Angelo De Claro, Amylou C Dueck, Tarec...
The Lancet Haematology

Seeking solutions to old problems in elderly patients with lymphoma

The Lancet Haematology Fecha de publicación: June 2018 DOI: https://doi.org/10.1016/S2352-3026(18)30065-6 Autores: Andrés José María Ferreri Background: Diffuse large B-cell lymphoma is diagnosed in elderly patients with increasing frequency, with 40% of...